These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21193535)

  • 1. Multistate analysis of interval-censored longitudinal data: application to a cohort study on performance status among patients diagnosed with cancer.
    Sutradhar R; Barbera L; Seow H; Howell D; Husain A; Dudgeon D
    Am J Epidemiol; 2011 Feb; 173(4):468-75. PubMed ID: 21193535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Markov multistate analysis of the relationship between performance status and death among an ambulatory population of cancer patients.
    Sutradhar R; Barbera L
    Palliat Med; 2014 Feb; 28(2):184-90. PubMed ID: 23935016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the longitudinal transitions of performance status in cancer outpatients: time to discuss palliative care.
    Sutradhar R; Seow H; Earle C; Dudgeon D; Atzema C; Husain A; Howell D; Liu Y; Sussman J; Barbera L
    J Pain Symptom Manage; 2013 Apr; 45(4):726-34. PubMed ID: 22940563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation.
    Foucher Y; Giral M; Soulillou JP; Daures JP
    Stat Med; 2007 Dec; 26(30):5381-93. PubMed ID: 17987670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Markov Multistate Models to Examine the Progression of Symptom Severity Among an Ambulatory Population of Cancer Patients: Are Certain Symptoms Better Managed Than Others?
    Jia J; Barbera L; Sutradhar R
    J Pain Symptom Manage; 2016 Feb; 51(2):232-9. PubMed ID: 26477828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.
    Cole BF; Bonetti M; Zaslavsky AM; Gelber RD
    Stat Med; 2005 Aug; 24(15):2317-34. PubMed ID: 15977292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
    Boher JM; Pujol JL; Grenier J; Daurès JP
    Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of nonhomogenous Markov models for analyzing longitudinal caries risk.
    Kopycka-Kedzierawski DT; Billings RJ
    Community Dent Oral Epidemiol; 2006 Apr; 34(2):123-9. PubMed ID: 16515676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decision analysis in radiology using Markov models].
    Golder W
    Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of the progression of functional disability in patients with ankylosing spondylitis.
    Ward MM
    J Rheumatol; 2002 Jul; 29(7):1420-5. PubMed ID: 12136900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing longitudinal data with patients in different disease states during follow-up and death as final state.
    le Cessie S; de Vries EG; Buijs C; Post WJ
    Stat Med; 2009 Dec; 28(30):3829-43. PubMed ID: 19876950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computing short-interval transition matrices of a discrete-time Markov chain from partially observed data.
    Charitos T; de Waal PR; van der Gaag LC
    Stat Med; 2008 Mar; 27(6):905-21. PubMed ID: 17579926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description and prediction of physical functional disability in psoriatic arthritis: a longitudinal analysis using a Markov model approach.
    Husted JA; Tom BD; Farewell VT; Schentag CT; Gladman DD
    Arthritis Rheum; 2005 Jun; 53(3):404-9. PubMed ID: 15934101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of asthma control under a Markov assumption with use of covariates.
    Saint-Pierre P; Combescure C; Daurès JP; Godard P
    Stat Med; 2003 Dec; 22(24):3755-70. PubMed ID: 14673936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative survival multistate Markov model.
    Huszti E; Abrahamowicz M; Alioum A; Binquet C; Quantin C
    Stat Med; 2012 Feb; 31(3):269-86. PubMed ID: 22052528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparametric estimation in a Markov "illness-death" process from interval censored observations with missing intermediate transition status.
    Frydman H; Szarek M
    Biometrics; 2009 Mar; 65(1):143-51. PubMed ID: 18505421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a condition-specific instrument for patients with low back pain/leg symptoms really necessary? The responsiveness of the Oswestry Disability Index, MODEMS, and the SF-36.
    Walsh TL; Hanscom B; Lurie JD; Weinstein JN
    Spine (Phila Pa 1976); 2003 Mar; 28(6):607-15. PubMed ID: 12642770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.
    Kobelt G; Lindgren P; Lindroth Y; Jacobson L; Eberhardt K
    Rheumatology (Oxford); 2005 Sep; 44(9):1169-75. PubMed ID: 15956093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial multistate transitional models for longitudinal event data.
    Nathoo FS; Dean CB
    Biometrics; 2008 Mar; 64(1):271-9. PubMed ID: 17425639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiparametric estimation in a three-state duration-dependent Markov model from interval-censored observations with application to AIDS data.
    Frydman H
    Biometrics; 1995 Jun; 51(2):502-11. PubMed ID: 7662839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.